TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02231658

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“Too challenging to recruit appropriate participants at an acceptable speed.”

The sponsor’s own words in the registry.

Life of this trial

201420152016201720182019Registered2014-09-01Started2015-07-16Stopped2018-07-23

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
Profil Institut für Stoffwechselforschung GmbH
Sponsor type
Industry
Conditions
Diabetes Mellitus
Interventions
Liraglutide; Lixisenatide
Participants
109
Sites
2
Countries
Germany

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.